Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
SRPT
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -71.2%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
sarepta
therapeutics
class
action
investors
lawsuit
firm
elevidys
securities
against
about
safety
deadline
duchenne
muscular
dystrophy
therapy
misleading
gene
patient
SRPT
Sarepta Therapeutics,, Inc. Common Stock
Stonvex
StonvexStonvexStonvexStonvex